120
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Isolated Sixth Nerve Palsy After Intravitreal Bevacizumab Injection

, MD, , MD, , MD & , MD
Pages 18-20 | Received 13 Sep 2009, Accepted 17 Dec 2009, Published online: 15 Mar 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Cagatay Caglar, Sücattin Ilker Kocamis & Mustafa Durmus. (2016) Isolated sixth nerve palsy after intravitreal ranibizumab injection. Cutaneous and Ocular Toxicology 35:3, pages 248-250.
Read now

Articles from other publishers (8)

Ezgi Değerli, Gülin Alkan, Nihan Şentürk Öztaş, Şahin Bedir, Sümeyra Derin & Nebi Serkan Demirci. (2021) Bevacizumab-induced isolated oculomotor nerve palsy in glioblastoma multiforme. Journal of Oncology Pharmacy Practice 28:3, pages 746-749.
Crossref
Helio V. Neves da Silva, John Placide, Anne Duong, Yasmyne Ronquillo, Shannon McCabe & Majid Moshirfar. (2022) Ocular adverse effects of therapeutic biologics. Therapeutic Advances in Ophthalmology 14, pages 251584142110708.
Crossref
Kewal K. JainKewal K. Jain. 2021. Drug-induced Neurological Disorders. Drug-induced Neurological Disorders 395 399 .
Mazdak Momeni, Laura Veras & Konstantin Zakashansky. (2016) Bevacizumab-induced transient sixth nerve palsy in ovarian cancer: A case report. Asia-Pacific Journal of Clinical Oncology 12:1, pages e196-e198.
Crossref
K Ghasemi Falavarjani & Q D Nguyen. (2013) Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature. Eye 27:7, pages 787-794.
Crossref
Morgan G Cadman-Davies, Rajiv Chandegra, Stephen M Scotcher & Neeraj Prasad. (2012) Nicorandil induced ophthalmoplegic migraine. JRSM Short Reports 3:6, pages 1-3.
Crossref
Jae Ho JungJung Hoon LeeJi Eun LeeHee Young Choi. (2012) Safety of Bevacizumab on Extraocular Muscle in a Rabbit Model. Korean Journal of Ophthalmology 26:4, pages 290.
Crossref
Michael Tolentino. (2011) Systemic and Ocular Safety of Intravitreal Anti-VEGF Therapies for Ocular Neovascular Disease. Survey of Ophthalmology 56:2, pages 95-113.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.